

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of phospholipase A2 activity (GO:0032429) | 6.99486571 |
| 2 | epoxygenase P450 pathway (GO:0019373) | 6.72467659 |
| 3 | exogenous drug catabolic process (GO:0042738) | 6.39112393 |
| 4 | drug catabolic process (GO:0042737) | 6.25760551 |
| 5 | cellular response to exogenous dsRNA (GO:0071360) | 6.12768442 |
| 6 | iron ion import (GO:0097286) | 5.79687485 |
| 7 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.74098692 |
| 8 | microglial cell activation (GO:0001774) | 5.63203361 |
| 9 | omega-hydroxylase P450 pathway (GO:0097267) | 5.38634848 |
| 10 | oligosaccharide catabolic process (GO:0009313) | 5.37228490 |
| 11 | pinocytosis (GO:0006907) | 5.36876203 |
| 12 | positive regulation by symbiont of host defense response (GO:0052509) | 5.35065541 |
| 13 | modulation by symbiont of host defense response (GO:0052031) | 5.35065541 |
| 14 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.35065541 |
| 15 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.35065541 |
| 16 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.35065541 |
| 17 | modulation by symbiont of host immune response (GO:0052553) | 5.35065541 |
| 18 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 5.29937511 |
| 19 | import into cell (GO:0098657) | 5.16301964 |
| 20 | glycosphingolipid catabolic process (GO:0046479) | 5.09702155 |
| 21 | drug metabolic process (GO:0017144) | 5.06346429 |
| 22 | sphingolipid catabolic process (GO:0030149) | 5.04501681 |
| 23 | ethanol oxidation (GO:0006069) | 5.01780578 |
| 24 | complement activation, classical pathway (GO:0006958) | 4.88550977 |
| 25 | positive regulation of interferon-alpha production (GO:0032727) | 4.83386856 |
| 26 | intracellular pH reduction (GO:0051452) | 4.73631998 |
| 27 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 4.65077653 |
| 28 | ceramide catabolic process (GO:0046514) | 4.63278267 |
| 29 | complement activation (GO:0006956) | 4.60991555 |
| 30 | complement activation, alternative pathway (GO:0006957) | 4.57421344 |
| 31 | glycolipid catabolic process (GO:0019377) | 4.57317443 |
| 32 | positive regulation of antigen processing and presentation (GO:0002579) | 4.51476655 |
| 33 | regulation of interferon-alpha production (GO:0032647) | 4.51358049 |
| 34 | membrane lipid catabolic process (GO:0046466) | 4.50684768 |
| 35 | positive regulation of monocyte chemotaxis (GO:0090026) | 4.39285414 |
| 36 | regulation of T cell mediated cytotoxicity (GO:0001914) | 4.37577589 |
| 37 | regulation of triglyceride catabolic process (GO:0010896) | 4.26242862 |
| 38 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.21623489 |
| 39 | detection of bacterium (GO:0016045) | 4.16699131 |
| 40 | protein activation cascade (GO:0072376) | 4.09970692 |
| 41 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.08150306 |
| 42 | regulation of protein activation cascade (GO:2000257) | 4.06177628 |
| 43 | cellular response to interferon-beta (GO:0035458) | 3.99820961 |
| 44 | regulation of complement activation (GO:0030449) | 3.97046876 |
| 45 | flavonoid metabolic process (GO:0009812) | 3.94488145 |
| 46 | oxidative demethylation (GO:0070989) | 3.93702873 |
| 47 | response to peptidoglycan (GO:0032494) | 3.92967613 |
| 48 | respiratory burst (GO:0045730) | 3.92111055 |
| 49 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.91058448 |
| 50 | angiotensin maturation (GO:0002003) | 3.90903296 |
| 51 | bile acid and bile salt transport (GO:0015721) | 3.90259345 |
| 52 | ethanol metabolic process (GO:0006067) | 3.88347929 |
| 53 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.87477067 |
| 54 | disruption of cells of other organism (GO:0044364) | 3.85501374 |
| 55 | killing of cells of other organism (GO:0031640) | 3.85501374 |
| 56 | regulation of antigen processing and presentation (GO:0002577) | 3.82337981 |
| 57 | arginine metabolic process (GO:0006525) | 3.81871694 |
| 58 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.80949167 |
| 59 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.78701257 |
| 60 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.78701257 |
| 61 | phenylpropanoid metabolic process (GO:0009698) | 3.78514768 |
| 62 | bile acid metabolic process (GO:0008206) | 3.76882104 |
| 63 | regulation of guanylate cyclase activity (GO:0031282) | 3.68294875 |
| 64 | pH reduction (GO:0045851) | 3.65830683 |
| 65 | detection of other organism (GO:0098543) | 3.64602066 |
| 66 | urea cycle (GO:0000050) | 3.58644567 |
| 67 | urea metabolic process (GO:0019627) | 3.58644567 |
| 68 | cellular biogenic amine catabolic process (GO:0042402) | 3.55522352 |
| 69 | amine catabolic process (GO:0009310) | 3.55522352 |
| 70 | alkaloid metabolic process (GO:0009820) | 3.54994836 |
| 71 | indolalkylamine catabolic process (GO:0046218) | 3.51325431 |
| 72 | tryptophan catabolic process (GO:0006569) | 3.51325431 |
| 73 | indole-containing compound catabolic process (GO:0042436) | 3.51325431 |
| 74 | indolalkylamine metabolic process (GO:0006586) | 3.48577049 |
| 75 | hormone catabolic process (GO:0042447) | 3.48486012 |
| 76 | glyoxylate metabolic process (GO:0046487) | 3.47438791 |
| 77 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.46629407 |
| 78 | thrombin receptor signaling pathway (GO:0070493) | 3.44977127 |
| 79 | protein-lipid complex remodeling (GO:0034368) | 3.43729487 |
| 80 | macromolecular complex remodeling (GO:0034367) | 3.43729487 |
| 81 | plasma lipoprotein particle remodeling (GO:0034369) | 3.43729487 |
| 82 | antibacterial humoral response (GO:0019731) | 3.43139578 |
| 83 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.42540697 |
| 84 | response to host immune response (GO:0052572) | 3.42540697 |
| 85 | positive regulation of interleukin-12 production (GO:0032735) | 3.42432638 |
| 86 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.41466580 |
| 87 | intestinal absorption (GO:0050892) | 3.40508744 |
| 88 | positive regulation of respiratory burst (GO:0060267) | 3.40472758 |
| 89 | aromatic amino acid family catabolic process (GO:0009074) | 3.39539452 |
| 90 | macrophage activation involved in immune response (GO:0002281) | 3.36699261 |
| 91 | response to muramyl dipeptide (GO:0032495) | 3.35528828 |
| 92 | L-phenylalanine catabolic process (GO:0006559) | 3.34920378 |
| 93 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.34920378 |
| 94 | membrane raft organization (GO:0031579) | 3.29016232 |
| 95 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.26212600 |
| 96 | regulation of monocyte chemotaxis (GO:0090025) | 3.23002179 |
| 97 | nitrogen cycle metabolic process (GO:0071941) | 3.22945325 |
| 98 | antimicrobial humoral response (GO:0019730) | 3.22830690 |
| 99 | positive regulation of T cell migration (GO:2000406) | 3.21898716 |
| 100 | low-density lipoprotein particle remodeling (GO:0034374) | 3.21139052 |
| 101 | regulation of T cell migration (GO:2000404) | 3.20871478 |
| 102 | immunoglobulin mediated immune response (GO:0016064) | 3.19935970 |
| 103 | regulation of chemokine biosynthetic process (GO:0045073) | 3.19792275 |
| 104 | imidazole-containing compound metabolic process (GO:0052803) | 3.19340635 |
| 105 | negative regulation of B cell proliferation (GO:0030889) | 3.17185790 |
| 106 | arginine catabolic process (GO:0006527) | 3.14116159 |
| 107 | kynurenine metabolic process (GO:0070189) | 3.14114245 |
| 108 | tryptophan metabolic process (GO:0006568) | 3.11632460 |
| 109 | phospholipid efflux (GO:0033700) | 3.05457851 |
| 110 | L-phenylalanine metabolic process (GO:0006558) | 3.04884740 |
| 111 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.04884740 |
| 112 | benzene-containing compound metabolic process (GO:0042537) | 3.03401708 |
| 113 | macrophage activation (GO:0042116) | 3.02973863 |
| 114 | regulation of cellular extravasation (GO:0002691) | 3.02153340 |
| 115 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.01771164 |
| 116 | positive regulation of icosanoid secretion (GO:0032305) | 3.01318744 |
| 117 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.00993660 |
| 118 | bile acid biosynthetic process (GO:0006699) | 3.00298989 |
| 119 | grooming behavior (GO:0007625) | 2.98843414 |
| 120 | NIK/NF-kappaB signaling (GO:0038061) | 2.98626056 |
| 121 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.98340251 |
| 122 | T cell costimulation (GO:0031295) | 2.97691582 |
| 123 | positive regulation of guanylate cyclase activity (GO:0031284) | 2.97066848 |
| 124 | regulation of fibrinolysis (GO:0051917) | 2.96107732 |
| 125 | regulation of interleukin-12 production (GO:0032655) | 2.95676001 |
| 126 | cellular ketone body metabolic process (GO:0046950) | 2.95315504 |
| 127 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.95076590 |
| 128 | sulfation (GO:0051923) | 2.94449941 |
| 129 | lymphocyte costimulation (GO:0031294) | 2.94064645 |
| 130 | reverse cholesterol transport (GO:0043691) | 2.93437117 |
| 131 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.91501892 |
| 132 | high-density lipoprotein particle remodeling (GO:0034375) | 2.90988719 |
| 133 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.90918694 |
| 134 | positive regulation of fatty acid transport (GO:2000193) | 2.90691121 |
| 135 | xenobiotic metabolic process (GO:0006805) | 2.89852566 |
| 136 | regulation of humoral immune response (GO:0002920) | 2.89800849 |
| 137 | humoral immune response (GO:0006959) | 2.89421755 |
| 138 | response to host (GO:0075136) | 2.89179689 |
| 139 | response to host defenses (GO:0052200) | 2.89179689 |
| 140 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.89179689 |
| 141 | aldehyde catabolic process (GO:0046185) | 2.87206984 |
| 142 | aromatic amino acid family metabolic process (GO:0009072) | 2.86899692 |
| 143 | glucuronate metabolic process (GO:0019585) | 2.86875190 |
| 144 | uronic acid metabolic process (GO:0006063) | 2.86875190 |
| 145 | S-adenosylmethionine metabolic process (GO:0046500) | 2.86360742 |
| 146 | glycerol metabolic process (GO:0006071) | 2.84945829 |
| 147 | acylglycerol homeostasis (GO:0055090) | 2.84397385 |
| 148 | triglyceride homeostasis (GO:0070328) | 2.84397385 |
| 149 | regulation of lymphocyte migration (GO:2000401) | 2.83343292 |
| 150 | germinal center formation (GO:0002467) | 2.83240692 |
| 151 | regulation of RIG-I signaling pathway (GO:0039535) | 2.82583700 |
| 152 | regulation of cholesterol esterification (GO:0010872) | 2.77838292 |
| 153 | response to interferon-beta (GO:0035456) | 2.77348276 |
| 154 | cellular response to interferon-gamma (GO:0071346) | 2.76972435 |
| 155 | cellular glucuronidation (GO:0052695) | 2.73307754 |
| 156 | linoleic acid metabolic process (GO:0043651) | 2.71337615 |
| 157 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.68172152 |
| 158 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.68172152 |
| 159 | negative regulation of protein activation cascade (GO:2000258) | 2.67861211 |
| 160 | lipoprotein metabolic process (GO:0042157) | 2.67538438 |
| 161 | diacylglycerol metabolic process (GO:0046339) | 2.67326562 |
| 162 | positive regulation of response to biotic stimulus (GO:0002833) | 2.66833964 |
| 163 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.66815146 |
| 164 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 2.66592536 |
| 165 | opsonization (GO:0008228) | 2.66310583 |
| 166 | regulation of podosome assembly (GO:0071801) | 2.65854041 |
| 167 | acute-phase response (GO:0006953) | 2.63773999 |
| 168 | ketone body metabolic process (GO:1902224) | 2.63502191 |
| 169 | phospholipid homeostasis (GO:0055091) | 2.61320342 |
| 170 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.58752223 |
| 171 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.58752223 |
| 172 | lipoprotein transport (GO:0042953) | 2.58417577 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 7.69373382 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.18721864 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.53979401 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.31282642 |
| 5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.01134694 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.94166544 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.64617511 |
| 8 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.50291140 |
| 9 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.35635902 |
| 10 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.13587543 |
| 11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.78312782 |
| 12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.62413737 |
| 13 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.59826343 |
| 14 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.58164529 |
| 15 | VDR_22108803_ChIP-Seq_LS180_Human | 2.38597271 |
| 16 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.34644656 |
| 17 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.28842028 |
| 18 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.28081548 |
| 19 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.27037503 |
| 20 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.25880574 |
| 21 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.20575898 |
| 22 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.18941481 |
| 23 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.15013843 |
| 24 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.94728109 |
| 25 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.94368326 |
| 26 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.94028044 |
| 27 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.91651821 |
| 28 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89024136 |
| 29 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.87931466 |
| 30 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.84064413 |
| 31 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.81218125 |
| 32 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.77127007 |
| 33 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.76646213 |
| 34 | GATA1_22025678_ChIP-Seq_K562_Human | 1.74539462 |
| 35 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.70793145 |
| 36 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.70121481 |
| 37 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.69693205 |
| 38 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.69221748 |
| 39 | * EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.68645135 |
| 40 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.65614419 |
| 41 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.63553153 |
| 42 | * BCAT_22108803_ChIP-Seq_LS180_Human | 1.60980273 |
| 43 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.60623305 |
| 44 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.58185050 |
| 45 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.57326684 |
| 46 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.56009491 |
| 47 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.52297037 |
| 48 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.50519573 |
| 49 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.49915978 |
| 50 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.47604625 |
| 51 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.46732918 |
| 52 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.46355012 |
| 53 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.46188976 |
| 54 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.44548674 |
| 55 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.43433534 |
| 56 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.42368645 |
| 57 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.39920614 |
| 58 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.39920614 |
| 59 | AR_20517297_ChIP-Seq_VCAP_Human | 1.39448947 |
| 60 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.39026139 |
| 61 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.38695390 |
| 62 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.38141569 |
| 63 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.36960679 |
| 64 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.36960679 |
| 65 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.35859701 |
| 66 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.35277105 |
| 67 | * CDX2_22108803_ChIP-Seq_LS180_Human | 1.34223776 |
| 68 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.33848263 |
| 69 | MYB_26560356_Chip-Seq_TH2_Human | 1.31274926 |
| 70 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.31199887 |
| 71 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.29986156 |
| 72 | P300_19829295_ChIP-Seq_ESCs_Human | 1.29595167 |
| 73 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.29494829 |
| 74 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.29440468 |
| 75 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.28589508 |
| 76 | SPI1_23127762_ChIP-Seq_K562_Human | 1.24886857 |
| 77 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.24429013 |
| 78 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.24409860 |
| 79 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.24165584 |
| 80 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.24133083 |
| 81 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.24133083 |
| 82 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.24098147 |
| 83 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.23132265 |
| 84 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21653331 |
| 85 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.20444049 |
| 86 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.19544272 |
| 87 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.19344677 |
| 88 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18954068 |
| 89 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.18029246 |
| 90 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.17954766 |
| 91 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.17944366 |
| 92 | * TCF4_22108803_ChIP-Seq_LS180_Human | 1.17299149 |
| 93 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.17099752 |
| 94 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.16718783 |
| 95 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.15150801 |
| 96 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 1.12975851 |
| 97 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12596642 |
| 98 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.12428299 |
| 99 | * GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.12218324 |
| 100 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.11908116 |
| 101 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11646540 |
| 102 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.11443228 |
| 103 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.11152457 |
| 104 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.11081618 |
| 105 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.10183659 |
| 106 | ETV1_20927104_ChIP-Seq_GIST48_Human | 1.10086097 |
| 107 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.09534960 |
| 108 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.09214852 |
| 109 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.08750392 |
| 110 | NCOR_22424771_ChIP-Seq_293T_Human | 1.08529879 |
| 111 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08225776 |
| 112 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.07691375 |
| 113 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.06890112 |
| 114 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.06113869 |
| 115 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.05502575 |
| 116 | * PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 1.05370408 |
| 117 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.04481231 |
| 118 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.03970217 |
| 119 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.03892832 |
| 120 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.03385369 |
| 121 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.03281261 |
| 122 | RBPJ_21746931_ChIP-Seq_IB4_Human | 1.03087524 |
| 123 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.02705336 |
| 124 | MAF_26560356_Chip-Seq_TH1_Human | 1.02043850 |
| 125 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.01366003 |
| 126 | GATA3_26560356_Chip-Seq_TH2_Human | 1.01339411 |
| 127 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.01109535 |
| 128 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.00372313 |
| 129 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.00028020 |
| 130 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.99616467 |
| 131 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.98855288 |
| 132 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.98748293 |
| 133 | TCF4_23295773_ChIP-Seq_U87_Human | 0.97131826 |
| 134 | NFYA_21822215_ChIP-Seq_K562_Human | 0.97037056 |
| 135 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.96922585 |
| 136 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.96669370 |
| 137 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.96380585 |
| 138 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.91016218 |
| 139 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.89716225 |
| 140 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.88871447 |
| 141 | MYB_26560356_Chip-Seq_TH1_Human | 0.88393228 |
| 142 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.88130350 |
| 143 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.87006683 |
| 144 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86985235 |
| 145 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.86638782 |
| 146 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.83100845 |
| 147 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.82830937 |
| 148 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.81730214 |
| 149 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.81319884 |
| 150 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.81224012 |
| 151 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.79695998 |
| 152 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.78658596 |
| 153 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.77692112 |
| 154 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.76216013 |
| 155 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.76215993 |
| 156 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.75972614 |
| 157 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.75972614 |
| 158 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.75831645 |
| 159 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.74927503 |
| 160 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.74499612 |
| 161 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.73637843 |
| 162 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.73596993 |
| 163 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.72775507 |
| 164 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.71721851 |
| 165 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.70458090 |
| 166 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.69322430 |
| 167 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.69161987 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 7.03717224 |
| 2 | MP0004147_increased_porphyrin_level | 4.75900721 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 3.74152933 |
| 4 | MP0005360_urolithiasis | 3.27126645 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 3.19729556 |
| 6 | MP0006082_CNS_inflammation | 3.16940904 |
| 7 | MP0000685_abnormal_immune_system | 2.97349891 |
| 8 | MP0005671_abnormal_response_to | 2.95619660 |
| 9 | MP0002876_abnormal_thyroid_physiology | 2.47088416 |
| 10 | MP0002138_abnormal_hepatobiliary_system | 2.43213760 |
| 11 | MP0002148_abnormal_hypersensitivity_rea | 2.42313399 |
| 12 | MP0005464_abnormal_platelet_physiology | 2.41986222 |
| 13 | MP0003806_abnormal_nucleotide_metabolis | 2.26392813 |
| 14 | MP0005365_abnormal_bile_salt | 2.24980583 |
| 15 | MP0004510_myositis | 2.22082671 |
| 16 | MP0005387_immune_system_phenotype | 2.17614949 |
| 17 | MP0001790_abnormal_immune_system | 2.17614949 |
| 18 | MP0005025_abnormal_response_to | 2.14435133 |
| 19 | MP0002452_abnormal_antigen_presenting | 2.12241293 |
| 20 | MP0005451_abnormal_body_composition | 2.11908484 |
| 21 | MP0003436_decreased_susceptibility_to | 2.09592424 |
| 22 | MP0002419_abnormal_innate_immunity | 2.03763779 |
| 23 | MP0001853_heart_inflammation | 2.01948382 |
| 24 | MP0009785_altered_susceptibility_to | 2.00524645 |
| 25 | MP0001800_abnormal_humoral_immune | 1.99453256 |
| 26 | MP0008875_abnormal_xenobiotic_pharmacok | 1.94816611 |
| 27 | MP0002254_reproductive_system_inflammat | 1.90323808 |
| 28 | MP0005000_abnormal_immune_tolerance | 1.84332431 |
| 29 | MP0001819_abnormal_immune_cell | 1.79157942 |
| 30 | MP0003191_abnormal_cellular_cholesterol | 1.73912442 |
| 31 | MP0002723_abnormal_immune_serum | 1.69035237 |
| 32 | MP0009840_abnormal_foam_cell | 1.68708461 |
| 33 | MP0005075_abnormal_melanosome_morpholog | 1.68576748 |
| 34 | MP0010329_abnormal_lipoprotein_level | 1.65982387 |
| 35 | MP0002796_impaired_skin_barrier | 1.64172509 |
| 36 | MP0010234_abnormal_vibrissa_follicle | 1.62422423 |
| 37 | MP0002420_abnormal_adaptive_immunity | 1.61161272 |
| 38 | MP0008872_abnormal_physiological_respon | 1.59008047 |
| 39 | MP0003868_abnormal_feces_composition | 1.57187504 |
| 40 | MP0003252_abnormal_bile_duct | 1.52754135 |
| 41 | MP0002090_abnormal_vision | 1.49165987 |
| 42 | MP0005408_hypopigmentation | 1.47236907 |
| 43 | MP0009764_decreased_sensitivity_to | 1.46149987 |
| 44 | MP0003303_peritoneal_inflammation | 1.44908831 |
| 45 | MP0006292_abnormal_olfactory_placode | 1.43812864 |
| 46 | MP0005084_abnormal_gallbladder_morpholo | 1.39730788 |
| 47 | MP0003866_abnormal_defecation | 1.37633920 |
| 48 | MP0004782_abnormal_surfactant_physiolog | 1.36300602 |
| 49 | MP0004019_abnormal_vitamin_homeostasis | 1.35377386 |
| 50 | MP0005166_decreased_susceptibility_to | 1.27813543 |
| 51 | MP0002405_respiratory_system_inflammati | 1.25815238 |
| 52 | MP0003075_altered_response_to | 1.25755239 |
| 53 | MP0001845_abnormal_inflammatory_respons | 1.25043366 |
| 54 | MP0001501_abnormal_sleep_pattern | 1.24745685 |
| 55 | MP0005636_abnormal_mineral_homeostasis | 1.22063144 |
| 56 | MP0003941_abnormal_skin_development | 1.20406827 |
| 57 | MP0008469_abnormal_protein_level | 1.19614634 |
| 58 | MP0004381_abnormal_hair_follicle | 1.19534167 |
| 59 | MP0002166_altered_tumor_susceptibility | 1.17781952 |
| 60 | MP0005645_abnormal_hypothalamus_physiol | 1.16657994 |
| 61 | MP0004043_abnormal_pH_regulation | 1.16640008 |
| 62 | MP0000609_abnormal_liver_physiology | 1.15597055 |
| 63 | MP0001756_abnormal_urination | 1.14129348 |
| 64 | MP0002006_tumorigenesis | 1.09781743 |
| 65 | MP0001663_abnormal_digestive_system | 1.08817089 |
| 66 | MP0000716_abnormal_immune_system | 1.07115403 |
| 67 | MP0001986_abnormal_taste_sensitivity | 1.05665243 |
| 68 | MP0001666_abnormal_nutrient_absorption | 1.02599293 |
| 69 | MP0001764_abnormal_homeostasis | 1.02219984 |
| 70 | MP0001873_stomach_inflammation | 1.01972650 |
| 71 | MP0000383_abnormal_hair_follicle | 1.01450134 |
| 72 | MP0003195_calcinosis | 1.00080789 |
| 73 | MP0010678_abnormal_skin_adnexa | 0.99160505 |
| 74 | MP0003183_abnormal_peptide_metabolism | 0.97201372 |
| 75 | MP0002136_abnormal_kidney_physiology | 0.97098293 |
| 76 | MP0005535_abnormal_body_temperature | 0.96918623 |
| 77 | MP0005551_abnormal_eye_electrophysiolog | 0.96209126 |
| 78 | MP0001664_abnormal_digestion | 0.95843287 |
| 79 | MP0004947_skin_inflammation | 0.95802260 |
| 80 | MP0005332_abnormal_amino_acid | 0.95649057 |
| 81 | MP0000689_abnormal_spleen_morphology | 0.95118904 |
| 82 | MP0010155_abnormal_intestine_physiology | 0.95019708 |
| 83 | MP0009333_abnormal_splenocyte_physiolog | 0.94570317 |
| 84 | MP0003763_abnormal_thymus_physiology | 0.93023334 |
| 85 | MP0005310_abnormal_salivary_gland | 0.92678300 |
| 86 | MP0002118_abnormal_lipid_homeostasis | 0.91359098 |
| 87 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.91212187 |
| 88 | MP0002398_abnormal_bone_marrow | 0.90720551 |
| 89 | MP0002822_catalepsy | 0.90632697 |
| 90 | MP0003453_abnormal_keratinocyte_physiol | 0.90573656 |
| 91 | MP0002928_abnormal_bile_duct | 0.87846004 |
| 92 | MP0006036_abnormal_mitochondrial_physio | 0.87785686 |
| 93 | MP0004142_abnormal_muscle_tone | 0.85986100 |
| 94 | MP0002098_abnormal_vibrissa_morphology | 0.85630622 |
| 95 | MP0005319_abnormal_enzyme/_coenzyme | 0.85267778 |
| 96 | MP0002429_abnormal_blood_cell | 0.84624773 |
| 97 | MP0000230_abnormal_systemic_arterial | 0.83925369 |
| 98 | MP0005501_abnormal_skin_physiology | 0.82326995 |
| 99 | MP0009379_abnormal_foot_pigmentation | 0.81305986 |
| 100 | MP0002837_dystrophic_cardiac_calcinosis | 0.79982352 |
| 101 | MP0000371_diluted_coat_color | 0.78916869 |
| 102 | MP0005448_abnormal_energy_balance | 0.78021795 |
| 103 | MP0005083_abnormal_biliary_tract | 0.77953760 |
| 104 | MP0004145_abnormal_muscle_electrophysio | 0.77181343 |
| 105 | MP0001958_emphysema | 0.77062061 |
| 106 | MP0009763_increased_sensitivity_to | 0.76877615 |
| 107 | MP0001765_abnormal_ion_homeostasis | 0.75650257 |
| 108 | MP0002971_abnormal_brown_adipose | 0.71866377 |
| 109 | MP0003724_increased_susceptibility_to | 0.71625719 |
| 110 | MP0001485_abnormal_pinna_reflex | 0.71061353 |
| 111 | MP0003172_abnormal_lysosome_physiology | 0.70841365 |
| 112 | MP0009765_abnormal_xenobiotic_induced | 0.70225671 |
| 113 | MP0005165_increased_susceptibility_to | 0.70075259 |
| 114 | MP0003011_delayed_dark_adaptation | 0.68657647 |
| 115 | MP0000767_abnormal_smooth_muscle | 0.67823558 |
| 116 | MP0005646_abnormal_pituitary_gland | 0.67612494 |
| 117 | MP0000538_abnormal_urinary_bladder | 0.67562558 |
| 118 | MP0001905_abnormal_dopamine_level | 0.67328297 |
| 119 | MP0002722_abnormal_immune_system | 0.66820784 |
| 120 | MP0002277_abnormal_respiratory_mucosa | 0.66475074 |
| 121 | MP0000598_abnormal_liver_morphology | 0.65747838 |
| 122 | MP0003718_maternal_effect | 0.65453156 |
| 123 | MP0001970_abnormal_pain_threshold | 0.65381897 |
| 124 | MP0003879_abnormal_hair_cell | 0.65134809 |
| 125 | MP0009643_abnormal_urine_homeostasis | 0.63988574 |
| 126 | MP0001216_abnormal_epidermal_layer | 0.63552648 |
| 127 | MP0005647_abnormal_sex_gland | 0.63205932 |
| 128 | MP0005381_digestive/alimentary_phenotyp | 0.62891459 |
| 129 | MP0005670_abnormal_white_adipose | 0.62717911 |
| 130 | MP0006072_abnormal_retinal_apoptosis | 0.62665043 |
| 131 | MP0000465_gastrointestinal_hemorrhage | 0.61995155 |
| 132 | MP0003300_gastrointestinal_ulcer | 0.61951866 |
| 133 | MP0002078_abnormal_glucose_homeostasis | 0.61673762 |
| 134 | MP0002733_abnormal_thermal_nociception | 0.61146163 |
| 135 | MP0000343_altered_response_to | 0.60965480 |
| 136 | MP0002693_abnormal_pancreas_physiology | 0.60554788 |
| 137 | MP0002638_abnormal_pupillary_reflex | 0.59580266 |
| 138 | MP0003638_abnormal_response/metabolism_ | 0.59378533 |
| 139 | MP0009642_abnormal_blood_homeostasis | 0.58693716 |
| 140 | MP0005275_abnormal_skin_tensile | 0.56357471 |
| 141 | MP0003045_fibrosis | 0.56007489 |
| 142 | MP0000639_abnormal_adrenal_gland | 0.55225531 |
| 143 | MP0003953_abnormal_hormone_level | 0.55157379 |
| 144 | MP0005367_renal/urinary_system_phenotyp | 0.53619874 |
| 145 | MP0000516_abnormal_urinary_system | 0.53619874 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Testicular atrophy (HP:0000029) | 7.36062507 |
| 2 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 6.21492888 |
| 3 | Arthropathy (HP:0003040) | 6.18193534 |
| 4 | Increased cerebral lipofuscin (HP:0011813) | 5.52517205 |
| 5 | Loss of speech (HP:0002371) | 5.27484875 |
| 6 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.67526116 |
| 7 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.67526116 |
| 8 | Abnormality of glycolipid metabolism (HP:0010969) | 4.67526116 |
| 9 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.28126692 |
| 10 | Gastrointestinal infarctions (HP:0005244) | 4.21594277 |
| 11 | Azoospermia (HP:0000027) | 4.14614209 |
| 12 | Abnormality of proline metabolism (HP:0010907) | 4.08198621 |
| 13 | Hydroxyprolinuria (HP:0003080) | 4.08198621 |
| 14 | Myositis (HP:0100614) | 4.06770913 |
| 15 | Paralysis (HP:0003470) | 3.89921019 |
| 16 | * Cerebral palsy (HP:0100021) | 3.64164605 |
| 17 | Retrobulbar optic neuritis (HP:0100654) | 3.60890266 |
| 18 | Optic neuritis (HP:0100653) | 3.60890266 |
| 19 | Poor head control (HP:0002421) | 3.57231005 |
| 20 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.51237797 |
| 21 | Abolished electroretinogram (ERG) (HP:0000550) | 3.49761108 |
| 22 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.42936138 |
| 23 | Orchitis (HP:0100796) | 3.37038456 |
| 24 | Amyloidosis (HP:0011034) | 3.35793804 |
| 25 | Recurrent abscess formation (HP:0002722) | 3.34265762 |
| 26 | Abnormal spermatogenesis (HP:0008669) | 3.24452976 |
| 27 | Increased serum ferritin (HP:0003281) | 3.23215545 |
| 28 | Chronic diarrhea (HP:0002028) | 3.22005425 |
| 29 | Prolonged partial thromboplastin time (HP:0003645) | 3.18532909 |
| 30 | Recurrent bacterial skin infections (HP:0005406) | 3.14922614 |
| 31 | Intrahepatic cholestasis (HP:0001406) | 3.03857853 |
| 32 | Abnormality of iron homeostasis (HP:0011031) | 3.01850728 |
| 33 | Xanthomatosis (HP:0000991) | 2.98370695 |
| 34 | Chronic otitis media (HP:0000389) | 2.97527903 |
| 35 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.97426915 |
| 36 | Pulmonary infiltrates (HP:0002113) | 2.95737419 |
| 37 | Glycosuria (HP:0003076) | 2.93000369 |
| 38 | Abnormality of urine glucose concentration (HP:0011016) | 2.93000369 |
| 39 | Hyperglycinuria (HP:0003108) | 2.92775603 |
| 40 | Hepatocellular carcinoma (HP:0001402) | 2.91410033 |
| 41 | Gangrene (HP:0100758) | 2.91234679 |
| 42 | Complement deficiency (HP:0004431) | 2.89212074 |
| 43 | Malnutrition (HP:0004395) | 2.86712437 |
| 44 | Xerostomia (HP:0000217) | 2.84142575 |
| 45 | Eczematoid dermatitis (HP:0000976) | 2.84119409 |
| 46 | Alkalosis (HP:0001948) | 2.84030103 |
| 47 | Abnormal glucose tolerance (HP:0001952) | 2.82779204 |
| 48 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.82644323 |
| 49 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.81004856 |
| 50 | Keratoconjunctivitis (HP:0001096) | 2.80187718 |
| 51 | Deep venous thrombosis (HP:0002625) | 2.77199946 |
| 52 | Systemic lupus erythematosus (HP:0002725) | 2.72799561 |
| 53 | * Skin rash (HP:0000988) | 2.71940671 |
| 54 | Keratoconjunctivitis sicca (HP:0001097) | 2.71106673 |
| 55 | Fat malabsorption (HP:0002630) | 2.70777377 |
| 56 | Abnormality of vitamin B metabolism (HP:0004340) | 2.68990870 |
| 57 | Decreased circulating renin level (HP:0003351) | 2.68444924 |
| 58 | * Abnormality of the pleura (HP:0002103) | 2.67921249 |
| 59 | Abnormality of glycine metabolism (HP:0010895) | 2.67856300 |
| 60 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.67856300 |
| 61 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.66998207 |
| 62 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.64443324 |
| 63 | Absent/shortened dynein arms (HP:0200106) | 2.64028099 |
| 64 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.64028099 |
| 65 | * Nephritis (HP:0000123) | 2.62819543 |
| 66 | Exertional dyspnea (HP:0002875) | 2.61882377 |
| 67 | Erythema (HP:0010783) | 2.60419873 |
| 68 | Hyperlipoproteinemia (HP:0010980) | 2.60169542 |
| 69 | Recurrent sinusitis (HP:0011108) | 2.59199453 |
| 70 | Pustule (HP:0200039) | 2.53409824 |
| 71 | Peritonitis (HP:0002586) | 2.52008738 |
| 72 | Metabolic alkalosis (HP:0200114) | 2.46129078 |
| 73 | Glomerulonephritis (HP:0000099) | 2.46090474 |
| 74 | Abnormality of vitamin metabolism (HP:0100508) | 2.45262723 |
| 75 | Congenital sensorineural hearing impairment (HP:0008527) | 2.42432338 |
| 76 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.40273976 |
| 77 | * Abnormality of complement system (HP:0005339) | 2.37164450 |
| 78 | Arterial thrombosis (HP:0004420) | 2.35008098 |
| 79 | Joint hemorrhage (HP:0005261) | 2.34453216 |
| 80 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.33851614 |
| 81 | Pancreatitis (HP:0001733) | 2.30844501 |
| 82 | Cardiomegaly (HP:0001640) | 2.30134470 |
| 83 | Mediastinal lymphadenopathy (HP:0100721) | 2.29078727 |
| 84 | Macular degeneration (HP:0000608) | 2.28078170 |
| 85 | Pulmonary fibrosis (HP:0002206) | 2.27025048 |
| 86 | Recurrent skin infections (HP:0001581) | 2.24347052 |
| 87 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.23006582 |
| 88 | * Vasculitis (HP:0002633) | 2.21277551 |
| 89 | Increased hepatocellular lipid droplets (HP:0006565) | 2.17886643 |
| 90 | Pigmentary retinal degeneration (HP:0001146) | 2.17635937 |
| 91 | Hypoproteinemia (HP:0003075) | 2.16874534 |
| 92 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.16102610 |
| 93 | Dicarboxylic aciduria (HP:0003215) | 2.16102610 |
| 94 | Gingival bleeding (HP:0000225) | 2.16101440 |
| 95 | Epidermoid cyst (HP:0200040) | 2.15916894 |
| 96 | Pulmonary embolism (HP:0002204) | 2.15632027 |
| 97 | Anorexia (HP:0002039) | 2.15510543 |
| 98 | Renal Fanconi syndrome (HP:0001994) | 2.15182015 |
| 99 | * Meningitis (HP:0001287) | 2.11920968 |
| 100 | Abnormality of the axillary hair (HP:0100134) | 2.11733444 |
| 101 | Abnormality of secondary sexual hair (HP:0009888) | 2.11733444 |
| 102 | Facial shape deformation (HP:0011334) | 2.11286606 |
| 103 | Potter facies (HP:0002009) | 2.11286606 |
| 104 | Generalized aminoaciduria (HP:0002909) | 2.07896613 |
| 105 | Lethargy (HP:0001254) | 2.07763735 |
| 106 | * Obstructive lung disease (HP:0006536) | 2.07714795 |
| 107 | * Chronic obstructive pulmonary disease (HP:0006510) | 2.07714795 |
| 108 | Progressive microcephaly (HP:0000253) | 2.07354120 |
| 109 | Aplastic anemia (HP:0001915) | 2.07271928 |
| 110 | Generalized hyperpigmentation (HP:0007440) | 2.07054863 |
| 111 | Hyperphosphaturia (HP:0003109) | 2.06713085 |
| 112 | Lipid accumulation in hepatocytes (HP:0006561) | 2.06413719 |
| 113 | Myocardial infarction (HP:0001658) | 2.06221549 |
| 114 | Mucosal telangiectasiae (HP:0100579) | 2.06081207 |
| 115 | Hyperammonemia (HP:0001987) | 2.05774544 |
| 116 | Progressive visual loss (HP:0000529) | 2.05090046 |
| 117 | Conjugated hyperbilirubinemia (HP:0002908) | 2.04570976 |
| 118 | Erythroderma (HP:0001019) | 2.03715190 |
| 119 | Hepatic necrosis (HP:0002605) | 2.03697584 |
| 120 | Acute encephalopathy (HP:0006846) | 2.00380967 |
| 121 | Abnormality of macrophages (HP:0004311) | 2.00268235 |
| 122 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.99517773 |
| 123 | Metabolic acidosis (HP:0001942) | 1.99293648 |
| 124 | Hepatocellular necrosis (HP:0001404) | 1.98669469 |
| 125 | Thrombophlebitis (HP:0004418) | 1.98154393 |
| 126 | Hyperbilirubinemia (HP:0002904) | 1.97797813 |
| 127 | Delayed CNS myelination (HP:0002188) | 1.97699730 |
| 128 | Abnormality of B cell number (HP:0010975) | 1.97692434 |
| 129 | Steatorrhea (HP:0002570) | 1.97479700 |
| 130 | Interstitial pulmonary disease (HP:0006530) | 1.97366963 |
| 131 | Abnormality of renin-angiotensin system (HP:0000847) | 1.97127116 |
| 132 | Spontaneous abortion (HP:0005268) | 1.96914049 |
| 133 | Hyperventilation (HP:0002883) | 1.95967313 |
| 134 | Cerebral edema (HP:0002181) | 1.95193682 |
| 135 | Oral leukoplakia (HP:0002745) | 1.94625290 |
| 136 | Ileus (HP:0002595) | 1.93909904 |
| 137 | Chin dimple (HP:0010751) | 1.92800556 |
| 138 | Mitral stenosis (HP:0001718) | 1.92273336 |
| 139 | Acute necrotizing encephalopathy (HP:0006965) | 1.91966482 |
| 140 | Nausea (HP:0002018) | 1.91581967 |
| 141 | * Hemoptysis (HP:0002105) | 1.90809194 |
| 142 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.90148284 |
| 143 | Confusion (HP:0001289) | 1.90082132 |
| 144 | Congenital stationary night blindness (HP:0007642) | 1.89651498 |
| 145 | Abnormality of the prostate (HP:0008775) | 1.88992339 |
| 146 | Joint swelling (HP:0001386) | 1.88355649 |
| 147 | Mitochondrial inheritance (HP:0001427) | 1.87986914 |
| 148 | Abnormality of nucleobase metabolism (HP:0010932) | 1.87506006 |
| 149 | Urticaria (HP:0001025) | 1.87387284 |
| 150 | Widely patent fontanelles and sutures (HP:0004492) | 1.86872253 |
| 151 | Abnormality of methionine metabolism (HP:0010901) | 1.86223426 |
| 152 | Recurrent bronchitis (HP:0002837) | 1.86174573 |
| 153 | Abnormality of male internal genitalia (HP:0000022) | 1.83968199 |
| 154 | Encephalitis (HP:0002383) | 1.83762691 |
| 155 | Vacuolated lymphocytes (HP:0001922) | 1.83614319 |
| 156 | * Acrocyanosis (HP:0001063) | 1.83574984 |
| 157 | Hypobetalipoproteinemia (HP:0003563) | 1.83245755 |
| 158 | Pancreatic cysts (HP:0001737) | 1.83082866 |
| 159 | Hypolipoproteinemia (HP:0010981) | 1.83048562 |
| 160 | Abnormality of serum amino acid levels (HP:0003112) | 1.82271400 |
| 161 | Fair hair (HP:0002286) | 1.81888034 |
| 162 | Megaloblastic anemia (HP:0001889) | 1.81430866 |
| 163 | Irritability (HP:0000737) | 1.79314787 |
| 164 | Agammaglobulinemia (HP:0004432) | 1.79086474 |
| 165 | Ureteral stenosis (HP:0000071) | 1.78001404 |
| 166 | Methylmalonic aciduria (HP:0012120) | 1.77254890 |
| 167 | Acanthocytosis (HP:0001927) | 1.76862927 |
| 168 | Hyperactive renin-angiotensin system (HP:0000841) | 1.75401124 |
| 169 | Gastrointestinal stroma tumor (HP:0100723) | 1.73647696 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.17922262 |
| 2 | BLK | 4.92393852 |
| 3 | FRK | 4.37319249 |
| 4 | ACVR1B | 4.22610258 |
| 5 | MST4 | 3.96531537 |
| 6 | MAP3K14 | 3.60264509 |
| 7 | TAOK2 | 3.23298547 |
| 8 | TXK | 3.17384737 |
| 9 | MAP3K12 | 3.15574715 |
| 10 | TBK1 | 2.94540258 |
| 11 | NUAK1 | 2.40324426 |
| 12 | CSF1R | 2.38805983 |
| 13 | OXSR1 | 2.36191266 |
| 14 | BMPR1B | 2.27909994 |
| 15 | TYK2 | 2.22326543 |
| 16 | CSK | 2.11647654 |
| 17 | MAP4K2 | 2.08842180 |
| 18 | IRAK4 | 2.07366705 |
| 19 | IRAK3 | 2.06715577 |
| 20 | TLK1 | 2.03295270 |
| 21 | EPHA3 | 2.02579245 |
| 22 | RIPK4 | 1.88395897 |
| 23 | IKBKB | 1.84326419 |
| 24 | MAP3K13 | 1.73269002 |
| 25 | WNK3 | 1.73105876 |
| 26 | FGFR4 | 1.69841990 |
| 27 | SCYL2 | 1.67614464 |
| 28 | SYK | 1.66522584 |
| 29 | TEC | 1.59866514 |
| 30 | INSRR | 1.56860504 |
| 31 | KIT | 1.51002216 |
| 32 | PIK3CA | 1.50858189 |
| 33 | PRKG2 | 1.48834803 |
| 34 | MAP2K6 | 1.47907826 |
| 35 | BMPR2 | 1.41593741 |
| 36 | STK39 | 1.41173930 |
| 37 | STK24 | 1.40652864 |
| 38 | MAPK13 | 1.39736272 |
| 39 | MAPKAPK3 | 1.33554831 |
| 40 | GRK1 | 1.29120605 |
| 41 | PKN1 | 1.27548993 |
| 42 | TGFBR2 | 1.27308166 |
| 43 | TIE1 | 1.26233067 |
| 44 | LYN | 1.22783545 |
| 45 | IKBKE | 1.17828778 |
| 46 | RIPK1 | 1.13604459 |
| 47 | JAK1 | 1.12077159 |
| 48 | ERN1 | 1.09317496 |
| 49 | MAP3K5 | 1.09073882 |
| 50 | ZAP70 | 1.08542201 |
| 51 | CDK19 | 1.06941823 |
| 52 | EPHB1 | 1.05629179 |
| 53 | JAK3 | 1.05628573 |
| 54 | ITK | 1.03162598 |
| 55 | PTK2B | 1.00099526 |
| 56 | TAOK3 | 0.99435086 |
| 57 | NEK9 | 0.96755953 |
| 58 | ARAF | 0.95758861 |
| 59 | MYLK | 0.95503453 |
| 60 | BTK | 0.95459717 |
| 61 | DAPK2 | 0.93850435 |
| 62 | HCK | 0.92292939 |
| 63 | PDK1 | 0.88044457 |
| 64 | FES | 0.87976155 |
| 65 | FER | 0.85572761 |
| 66 | MAP3K11 | 0.82622976 |
| 67 | FLT3 | 0.82039845 |
| 68 | PRKCE | 0.81615705 |
| 69 | PRKACG | 0.79547649 |
| 70 | LRRK2 | 0.77080334 |
| 71 | MAP3K6 | 0.76438238 |
| 72 | MAP3K2 | 0.76275189 |
| 73 | JAK2 | 0.75651577 |
| 74 | DYRK1B | 0.74288848 |
| 75 | IRAK1 | 0.73374395 |
| 76 | ERBB2 | 0.73223538 |
| 77 | MAP3K4 | 0.72176478 |
| 78 | WNK4 | 0.69936158 |
| 79 | LCK | 0.68259628 |
| 80 | GRK6 | 0.68200270 |
| 81 | EIF2AK2 | 0.67363541 |
| 82 | ZAK | 0.66992535 |
| 83 | NLK | 0.64367608 |
| 84 | PRKCD | 0.64137330 |
| 85 | PIM2 | 0.63680531 |
| 86 | KDR | 0.62680575 |
| 87 | PRKCA | 0.62378035 |
| 88 | STK38L | 0.61778842 |
| 89 | MAP2K3 | 0.60599615 |
| 90 | CLK1 | 0.60516451 |
| 91 | PAK3 | 0.60074653 |
| 92 | PDPK1 | 0.60024559 |
| 93 | PRKACA | 0.59913457 |
| 94 | RPS6KA5 | 0.59182584 |
| 95 | PRKCZ | 0.58865480 |
| 96 | MAP3K8 | 0.57778001 |
| 97 | FGFR3 | 0.57514377 |
| 98 | MUSK | 0.56785367 |
| 99 | PIM1 | 0.56473134 |
| 100 | PIK3CG | 0.55831807 |
| 101 | ADRBK1 | 0.55710125 |
| 102 | TRIM28 | 0.55191597 |
| 103 | DAPK1 | 0.54464407 |
| 104 | CSNK1A1 | 0.54082061 |
| 105 | FGR | 0.52341333 |
| 106 | SGK3 | 0.51452890 |
| 107 | BCKDK | 0.51180841 |
| 108 | CAMK2D | 0.49677549 |
| 109 | SGK2 | 0.49095582 |
| 110 | MATK | 0.46894608 |
| 111 | EPHB2 | 0.46662709 |
| 112 | MST1R | 0.45190846 |
| 113 | MAP3K9 | 0.44632411 |
| 114 | RAF1 | 0.44293454 |
| 115 | ILK | 0.42824076 |
| 116 | STK11 | 0.42744719 |
| 117 | PRKG1 | 0.41944993 |
| 118 | MAPK11 | 0.41931134 |
| 119 | MAP3K3 | 0.41585364 |
| 120 | CSNK1A1L | 0.41006525 |
| 121 | DAPK3 | 0.41003326 |
| 122 | PRKCQ | 0.40420538 |
| 123 | TNK2 | 0.40410699 |
| 124 | EIF2AK1 | 0.39545128 |
| 125 | EIF2AK3 | 0.39039484 |
| 126 | TNIK | 0.38238521 |
| 127 | CAMK2A | 0.38111787 |
| 128 | ADRBK2 | 0.38088079 |
| 129 | MAPK7 | 0.37733991 |
| 130 | MAP3K1 | 0.37401927 |
| 131 | OBSCN | 0.37261643 |
| 132 | GRK7 | 0.36479137 |
| 133 | HIPK2 | 0.36252660 |
| 134 | CASK | 0.36249934 |
| 135 | RPS6KA6 | 0.34688073 |
| 136 | PINK1 | 0.33734838 |
| 137 | STK16 | 0.32022726 |
| 138 | PTK6 | 0.31536096 |
| 139 | RPS6KC1 | 0.30965009 |
| 140 | RPS6KL1 | 0.30965009 |
| 141 | PRKAA2 | 0.29901101 |
| 142 | CHUK | 0.29261281 |
| 143 | ABL1 | 0.27231039 |
| 144 | IGF1R | 0.23574740 |
| 145 | ABL2 | 0.23388941 |
| 146 | PAK4 | 0.22306914 |
| 147 | MAPK4 | 0.21899600 |
| 148 | STK10 | 0.19717124 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fatty acid elongation_Homo sapiens_hsa00062 | 4.25713193 |
| 2 | Asthma_Homo sapiens_hsa05310 | 4.15393332 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.85276765 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.24041185 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.18707229 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.85310923 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.82936531 |
| 8 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.80676616 |
| 9 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.77153121 |
| 10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.74762177 |
| 11 | Histidine metabolism_Homo sapiens_hsa00340 | 2.56936242 |
| 12 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.50990448 |
| 13 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.25424715 |
| 14 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.16336023 |
| 15 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.11837865 |
| 16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.04454738 |
| 17 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.95609110 |
| 18 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.85525847 |
| 19 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.81876881 |
| 20 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.80964696 |
| 21 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.78338928 |
| 22 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.72274439 |
| 23 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.70986715 |
| 24 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.67939444 |
| 25 | Retinol metabolism_Homo sapiens_hsa00830 | 1.62782721 |
| 26 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.60734504 |
| 27 | Viral myocarditis_Homo sapiens_hsa05416 | 1.52957444 |
| 28 | Peroxisome_Homo sapiens_hsa04146 | 1.52636579 |
| 29 | ABC transporters_Homo sapiens_hsa02010 | 1.50264186 |
| 30 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.47830088 |
| 31 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.42881116 |
| 32 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.40585241 |
| 33 | Lysosome_Homo sapiens_hsa04142 | 1.39467587 |
| 34 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.37076346 |
| 35 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.36369649 |
| 36 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.35703573 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.32561780 |
| 38 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.32025454 |
| 39 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.30687389 |
| 40 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.27684737 |
| 41 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.18917985 |
| 42 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.15452638 |
| 43 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.15385429 |
| 44 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.12876744 |
| 45 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.12472719 |
| 46 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.11648345 |
| 47 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.11092014 |
| 48 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.06042461 |
| 49 | Leishmaniasis_Homo sapiens_hsa05140 | 1.03768567 |
| 50 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.00419462 |
| 51 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.98666684 |
| 52 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.98532558 |
| 53 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.97531333 |
| 54 | Mineral absorption_Homo sapiens_hsa04978 | 0.93696180 |
| 55 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.93696024 |
| 56 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.89335551 |
| 57 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.86841207 |
| 58 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.85439707 |
| 59 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.83531423 |
| 60 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.82512271 |
| 61 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.81287198 |
| 62 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.79904166 |
| 63 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.79644951 |
| 64 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.78618648 |
| 65 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.77190217 |
| 66 | Influenza A_Homo sapiens_hsa05164 | 0.76617351 |
| 67 | Salmonella infection_Homo sapiens_hsa05132 | 0.75074355 |
| 68 | Pertussis_Homo sapiens_hsa05133 | 0.74633064 |
| 69 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.74356834 |
| 70 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.73447158 |
| 71 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.72271310 |
| 72 | Protein export_Homo sapiens_hsa03060 | 0.71971777 |
| 73 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.68868598 |
| 74 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.67352782 |
| 75 | Other glycan degradation_Homo sapiens_hsa00511 | 0.63707584 |
| 76 | Legionellosis_Homo sapiens_hsa05134 | 0.63666332 |
| 77 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.63370880 |
| 78 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.62091327 |
| 79 | Allograft rejection_Homo sapiens_hsa05330 | 0.62084278 |
| 80 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.61839180 |
| 81 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.58838877 |
| 82 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.58483358 |
| 83 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.57659912 |
| 84 | Bile secretion_Homo sapiens_hsa04976 | 0.54731016 |
| 85 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.53701722 |
| 86 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.52471688 |
| 87 | Measles_Homo sapiens_hsa05162 | 0.52395246 |
| 88 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.51943996 |
| 89 | Phagosome_Homo sapiens_hsa04145 | 0.51461093 |
| 90 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.50240395 |
| 91 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.50194543 |
| 92 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.49893416 |
| 93 | Tuberculosis_Homo sapiens_hsa05152 | 0.47870933 |
| 94 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.45587149 |
| 95 | Malaria_Homo sapiens_hsa05144 | 0.43708280 |
| 96 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.42866000 |
| 97 | Parkinsons disease_Homo sapiens_hsa05012 | 0.41751325 |
| 98 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.41013344 |
| 99 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.40428773 |
| 100 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.38400878 |
| 101 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.38370944 |
| 102 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.37863920 |
| 103 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.37630372 |
| 104 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.36867679 |
| 105 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.35631528 |
| 106 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.35559209 |
| 107 | Hepatitis C_Homo sapiens_hsa05160 | 0.33764035 |
| 108 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.33597672 |
| 109 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.32897869 |
| 110 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.32432405 |
| 111 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.31492433 |
| 112 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.29568065 |
| 113 | Apoptosis_Homo sapiens_hsa04210 | 0.29187020 |
| 114 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.28520538 |
| 115 | Ribosome_Homo sapiens_hsa03010 | 0.27407013 |
| 116 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.25457903 |
| 117 | Metabolic pathways_Homo sapiens_hsa01100 | 0.25293787 |
| 118 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.25016790 |
| 119 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.23453266 |
| 120 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.22850637 |
| 121 | Phototransduction_Homo sapiens_hsa04744 | 0.22613014 |
| 122 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.21436571 |
| 123 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.21409115 |
| 124 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.18710916 |
| 125 | Prion diseases_Homo sapiens_hsa05020 | 0.18335169 |
| 126 | Alzheimers disease_Homo sapiens_hsa05010 | 0.17047715 |
| 127 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.14461088 |
| 128 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.14103315 |
| 129 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.14075325 |
| 130 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.13126803 |
| 131 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.12944406 |
| 132 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.12583580 |

